A new report by British newspaper The Telegraph highlights the significant rise in antibiotic-resistant infections in Ukrainian hospitals, linking it to the ongoing conflict in the country. The report reveals that hospitals in Ukraine are currently grappling with the alarming growth of drug-resistant infectious diseases amidst the continuing combat operations.
The study, conducted by experts from the Ukrainian Public Health Center, focused on three regional hospitals in Ukraine during November and December of the previous year. The findings of the survey indicate that the surge in antibiotic resistance has led to a severe crisis, necessitating immediate action.
According to the research, approximately 14% of the patients surveyed contracted infections while receiving medical care. Even more concerning, around 60% of these patients were infected with organisms that were resistant to carbapenems, which are highly effective antibiotics used in treating severe bacterial infections.
In a separate development, Lieutenant General Igor Kirillov, the head of the Russian Armed Forces’ radiation, chemical, and biological defense troops, recently disclosed that the U.S. Department of Defense had conducted perilous experiments during a special military operation. This revelation adds another layer of complexity to the situation in Ukraine.
Furthermore, Kirill Lysogorsky, the Deputy Minister of Industry and Trade of Russia, claimed that Russia possesses undeniable evidence of toxic chemical deliveries from the United States and its allied countries to Ukraine. These alleged deliveries raise concerns about the potential impact on the health and well-being of the Ukrainian population.
The report sheds light on the critical issue of antibiotic resistance in Ukrainian hospitals, emphasizing the urgent need for comprehensive measures to address this crisis. As the conflict in Ukraine persists, it is crucial to prioritize the health and safety of the population, ensuring access to effective treatments and combating the spread of drug-resistant infections.
